Future Directions in Malignant Hyperthermia Research and Patient Care
Authors:
- Sharon J. Hirshey DirksenSDSharon J. Hirshey Dirksen
- Marilyn Green LarachMLMarilyn Green Larach
- Henry RosenbergHRHenry Rosenberg
- Barbara W. BrandomBBBarbara W. Brandom
- Jerome ParnessJPJerome Parness
- Robert Scott LangRLRobert Scott Lang
- Meera GangadharanMGMeera Gangadharan
- Tyler PezalskiTPTyler Pezalski
- 1 November 2011
- journal article
- review article
- Published by Wolters Kluwer Health in Anesthesia & Analgesia
- Vol. 113 (5) , 1108-1119
Abstract
Erdisciplinary group of experts gathered to share new information and ideas. In this Special Article, we highlight key concepts and theories presented at the conference along with exciting new trends and challenges in MH research and patient care....Keywords
This publication has 74 references indexed in Scilit:
- Delayed Onset of Malignant Hyperthermia without Creatine Kinase Elevation in a Geriatric, Ryanodine Receptor Type 1 Gene Compound Heterozygous PatientAnesthesiology, 2007
- Malignant hyperthermiaOrphanet Journal of Rare Diseases, 2007
- Azumolene Inhibits a Component of Store-operated Calcium Entry Coupled to the Skeletal Muscle Ryanodine ReceptorJournal of Biological Chemistry, 2006
- Mutations inRYR1in malignant hyperthermia and central core diseaseHuman Mutation, 2006
- Malignant Hyperthermia in JapanAnesthesiology, 2006
- Genetic risk factors associated with lipid‐lowering drug‐induced myopathiesMuscle & Nerve, 2006
- Genetics of Malignant HyperthermiaThe Scientific World Journal, 2006
- Heat‐ and anesthesia‐induced malignant hyperthermia in an RyR1 knock‐in mouseThe FASEB Journal, 2005
- Malignant HyperthermiaJAMA, 2005
- Dantrolene Inhibition of Sarcoplasmic Reticulum Ca2+Release by Direct and Specific Action at Skeletal Muscle Ryanodine ReceptorsJournal of Biological Chemistry, 1997